IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODUCTION AND USE THEREOF FOR TREATMENT OF CANCER

Disclosed herein are compositions and methods for treating cancer in a subject. This involves administering an oncolytic virus containing a heterologous DNA sequence encoding one or more immunomodulatory and/or immunostimulatory polypeptide(s) of interest to the subject under conditions effective to...

Full description

Saved in:
Bibliographic Details
Main Authors STEINER, Philipp, HICKLIN, Daniel, SEIDEL-DUGAN, Cynthia, WILLS, Kenneth Nelson, WINSTON, William
Format Patent
LanguageEnglish
Published 09.01.2020
Subjects
ELECTRIC COMMUNICATION TECHNIQUE
ELECTRICITY
TELEPHONIC COMMUNICATION
Online AccessGet full text

Cover

Abstract Disclosed herein are compositions and methods for treating cancer in a subject. This involves administering an oncolytic virus containing a heterologous DNA sequence encoding one or more immunomodulatory and/or immunostimulatory polypeptide(s) of interest to the subject under conditions effective to enhance an anti-tumor immune response in the subject, and to treat cancer. It also relates to a method of enhancing the delivery to and distribution within a tumor mass of therapeutic viruses.
AbstractList Disclosed herein are compositions and methods for treating cancer in a subject. This involves administering an oncolytic virus containing a heterologous DNA sequence encoding one or more immunomodulatory and/or immunostimulatory polypeptide(s) of interest to the subject under conditions effective to enhance an anti-tumor immune response in the subject, and to treat cancer. It also relates to a method of enhancing the delivery to and distribution within a tumor mass of therapeutic viruses.
Author HICKLIN, Daniel
STEINER, Philipp
WILLS, Kenneth Nelson
SEIDEL-DUGAN, Cynthia
WINSTON, William
Author_xml – fullname: STEINER, Philipp
– fullname: HICKLIN, Daniel
– fullname: SEIDEL-DUGAN, Cynthia
– fullname: WILLS, Kenneth Nelson
– fullname: WINSTON, William
BookMark eNqNy70KwjAUhuEOOvh3DwdcFVoV1DEkpzTQ5EhyUuhUisRJ2kK9f6ziBTh9w_N-y2TW9V1cJIM2JlgypEIpmFwNZCWVNWsJQqGlSjtRQoVyQr8DYRUY5IKUB8rh5qajZE32K8EjcIEOJ8rJATsUbNDyp5XCSnTrZP5on2Pc_HaVbHNkWezj0DdxHNp77OKrCf6QHtI0O52vF5Ed_6vebME6xw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2020014798A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2020014798A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:06:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2020014798A13
Notes Application Number: US201816474898
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200109&DB=EPODOC&CC=US&NR=2020014798A1
ParticipantIDs epo_espacenet_US2020014798A1
PublicationCentury 2000
PublicationDate 20200109
PublicationDateYYYYMMDD 2020-01-09
PublicationDate_xml – month: 01
  year: 2020
  text: 20200109
  day: 09
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Trieza Therapeutics, Inc
RelatedCompanies_xml – name: Trieza Therapeutics, Inc
Score 3.2507074
Snippet Disclosed herein are compositions and methods for treating cancer in a subject. This involves administering an oncolytic virus containing a heterologous DNA...
SourceID epo
SourceType Open Access Repository
SubjectTerms ELECTRIC COMMUNICATION TECHNIQUE
ELECTRICITY
TELEPHONIC COMMUNICATION
Title IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODUCTION AND USE THEREOF FOR TREATMENT OF CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200109&DB=EPODOC&locale=&CC=US&NR=2020014798A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8IGvWmqPEDTRPNTi4yNhgciBldl2HYSvZB4EQo6xITM4jM-O_72gzlxK3tr23al7y-vvZ9IPTc7Rm2AYJRz_tWV7fMXOjLPMv1TpcvhZ1n7ZaQ3shB2PVT633WmdXQ584XRsUJ_VHBEYGjVsDvpTqvN_-PWK6yrdy-8g9oWr95ycDVKu24rX56NHc4oBPmMqIRMkhjLYwqzLL7PQd0pSN5kZaR9ul0KP1SNvtCxTtHxxOYrygvUE0UDXRKdrnXGugkqL68oVhx3_YSbUZBkIYsYG46dhIWzTEDlXw8T0YEA0FDNh1FzhhPKQEwfsFO6OKAJj5zY8w8PIlgoLIZUUgaU5z4NKIAgSqIk4g6iQztL_sSmbMmukJPHk2Ir8PSF3-UWqTx_j7Na1Qv1oW4QdgUwjZXHcMGFrYMbvCWxTnIrmzZ4hk3zFvUPDTT3WH4Hp3JqnqZ6DdRvfz6Fg8gq0v-qEj8C3qijvw
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjakDpk8V17drtYUjXD1ptm9GmY3say5qCIN1wFf99r6HTPe0t5JccycHl-F1yF4Se9L5iKOAY5Xyg6bKm5lxe5Fku93S24EaedTu8ykYOI91Ltbdpb9pAn9tcGFEn9EcURwSLWoK9l-K8Xv8HsWzxtnLzwj6ga_Xq0qEt1ey4K256JHs0dMbEJpZkWcM0kaK4xjRj0DeBKx0YQAoFWZqMqryU9a5TcU_R4RjkFeUZavCihY6t7d9rLXQU1lfe0Kytb3OO1n4YphEJiZ0GJiXxDBOg5MGM-hYGhUZk4sdmgCeOBWDyjM3IxqFDPWInmLh4HMNE8WZEIGniYOo5sQMQUEFMY8ekVWn_aqxV_VkTX6BH16GWJ8PS53-amqfJ7j7VS9QsVgW_Qljl3FCXPcUAE9YUprCOxhj4rmzRYRlT1GvU3ifpZj_8gI49GgbzwI_eb9FJBYkoxaCNmuXXN78Dv12ye6HuX0_PkeY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMMUNOMODULATORY+ONCOLYTIC+ADENOVIRAL+VECTORS%2C+AND+METHODS+OF+PRODUCTION+AND+USE+THEREOF+FOR+TREATMENT+OF+CANCER&rft.inventor=STEINER%2C+Philipp&rft.inventor=HICKLIN%2C+Daniel&rft.inventor=SEIDEL-DUGAN%2C+Cynthia&rft.inventor=WILLS%2C+Kenneth+Nelson&rft.inventor=WINSTON%2C+William&rft.date=2020-01-09&rft.externalDBID=A1&rft.externalDocID=US2020014798A1